SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-03-027213
Filing Date
2003-08-12
Accepted
2003-08-12 16:17:07
Documents
14
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2114315z10-q.htm 10-Q 272913
3 EXHIBIT 10.1 a2114315zex-10_1.txt EX-10.1 42874
4 EXHIBIT 10.2 a2114315zex-10_2.txt EX-10.2 50224
5 EXHIBIT 10.3 a2114315zex-10_3.txt EX-10.3 60595
6 EXHIBIT 10.4 a2114315zex-10_4.txt EX-10.4 67091
7 EXHIBIT 10.5 a2114315zex-10_5.txt EX-10.5 70926
8 EXHIBIT 10.6 a2114315zex-10_6.txt EX-10.6 67070
9 EXHIBIT 10.7 a2114315zex-10_7.txt EX-10.7 8926
10 EXHIBIT 12 a2114315zex-12.txt EX-12 2434
11 EXHIBIT 31.1 a2114315zex-31_1.txt EX-31.1 3243
12 EXHIBIT 31.2 a2114315zex-31_2.txt EX-31.2 3264
13 EXHIBIT 32.1 a2114315zex-32_1.txt EX-32.1 1414
14 EXHIBIT 32.2 a2114315zex-32_2.txt EX-32.2 1446
15 EXHIBIT 99.1 a2114315zex-99_1.txt EX-99.1 6632
  Complete submission text file 0001047469-03-027213.txt   662017
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-02189 | Film No.: 03837786
SIC: 2834 Pharmaceutical Preparations